{"id":246565,"date":"2022-07-05T17:11:33","date_gmt":"2022-07-05T17:11:33","guid":{"rendered":"https:\/\/teknomers.com\/es\/queja-de-la-compania-farmaceutica-alemana-curevac-contra-el-competidor-biontech-debido-a-la-innovadora-tecnologia-de-arn-mensajero-en-las-vacunas-corona\/"},"modified":"2022-07-05T17:11:34","modified_gmt":"2022-07-05T17:11:34","slug":"queja-de-la-compania-farmaceutica-alemana-curevac-contra-el-competidor-biontech-debido-a-la-innovadora-tecnologia-de-arn-mensajero-en-las-vacunas-corona","status":"publish","type":"post","link":"https:\/\/teknomers.com\/es\/queja-de-la-compania-farmaceutica-alemana-curevac-contra-el-competidor-biontech-debido-a-la-innovadora-tecnologia-de-arn-mensajero-en-las-vacunas-corona\/","title":{"rendered":"Queja de la compa\u00f1\u00eda farmac\u00e9utica alemana CureVac contra el competidor BioNTech debido a la innovadora tecnolog\u00eda de ARN mensajero en las vacunas corona"},"content":{"rendered":"\n<p>La empresa biotecnol\u00f3gica alemana CureVac anunci\u00f3 el martes que presentar\u00e1 una denuncia contra su competidor BioNTech, que desarroll\u00f3 una de las vacunas corona m\u00e1s exitosas junto con la compa\u00f1\u00eda farmac\u00e9utica Pfizer.  Seg\u00fan CureVac, BioNTech ha infringido la propiedad intelectual de CureVac con la innovadora tecnolog\u00eda de ARN mensajero (en holand\u00e9s, tambi\u00e9n &#8220;ARN mensajero&#8221;).  En una respuesta, BioNTech dice que su trabajo es &#8220;original&#8221; y que la empresa &#8220;se defender\u00e1 en\u00e9rgicamente de todas las acusaciones&#8221;.<br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.hln.be\/buitenland\/klacht-van-duits-farmabedrijf-curevac-tegen-concurrent-biontech-omwille-van-innovatieve-messenger-rna-technologie-in-coronavaccins~af8d1976\/\" rel=\"nofollow noopener\" target=\"_blank\">ttn-es-3<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La empresa biotecnol\u00f3gica alemana CureVac anunci\u00f3 el martes que presentar\u00e1 una denuncia contra su competidor BioNTech, que desarroll\u00f3<\/p>\n","protected":false},"author":1,"featured_media":246566,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[2884,86496,22774,1333,11341,110,573,86419,351,21097,17080,246,5633,13637,3368,1636],"class_list":["post-246565","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-alemana","tag-arn","tag-biontech","tag-compania","tag-competidor","tag-contra","tag-corona","tag-curevac","tag-debido","tag-farmaceutica","tag-innovadora","tag-las","tag-mensajero","tag-queja","tag-tecnologia","tag-vacunas"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/246565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/comments?post=246565"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/246565\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media\/246566"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media?parent=246565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/categories?post=246565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/tags?post=246565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}